Filing Details
- Accession Number:
- 0001140361-13-023186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-29 16:58:04
- Reporting Period:
- 2013-05-28
- Filing Date:
- 2013-05-29
- Accepted Time:
- 2013-05-29 16:58:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1319606 | Andrew Miller | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-28 | 10,000 | $8.43 | 22,468 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-28 | 22,468 | $38.51 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-05-28 | 10,000 | $0.00 | 10,000 | $8.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-04-28 | No | 4 | M | Direct |
Footnotes
- Represents the aggregate of sales effected on the same day at different prices.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $38.3555 to $38.68 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The stock option grant is 100% vested and immediately exercisable.